Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

EUROPEAN PROTEIN A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   2.1% 2.1% 2.1% 2.1% 2.1% 2.1% 1.5% 2.1%   Bankruptcy risk   1.1% 0.9% 0.6% 0.5% 0.5% 1.1% 7.8% 6.5%   Credit score (0-100)   86 90 98 98 98 83 31 37   Credit rating   A A AA AA AA A BB BBB   Credit limit (kDKK)   414.0 852.7 1,880.8 2,402.4 2,979.5 1,096.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   10,949 10,388 14,962 15,739 15,645 9,312 0.0 0.0   EBITDA   5,718 5,347 8,945 9,345 9,476 3,690 0.0 0.0   EBIT   4,531 4,025 7,465 7,221 6,399 473 0.0 0.0   Pre-tax profit (PTP)   3,742.0 3,338.0 6,799.0 6,842.0 5,977.0 7.8 0.0 0.0   Net earnings   2,902.0 2,584.0 5,288.0 5,341.0 4,664.0 21.9 0.0 0.0   Pre-tax profit without non-rec. items   3,742 3,338 6,799 6,842 5,977 7.8 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   7,863 8,696 9,841 20,564 19,089 18,006 0.0 0.0   Shareholders equity total   6,878 7,584 12,872 18,213 24,494 24,516 24,015 24,015   Interest-bearing liabilities   16,961 14,132 11,623 12,587 22,630 22,041 0.0 0.0   Balance sheet total (assets)   29,542 28,092 34,936 42,669 54,263 56,030 24,015 24,015   Net Debt   16,728 13,986 11,099 12,567 22,593 21,938 -24,015 -24,015     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   10,949 10,388 14,962 15,739 15,645 9,312 0.0 0.0   Gross profit growth   11.3% -5.1% 44.0% 5.2% -0.6% -40.5% -100.0% 0.0%   Employees   10 9 10 10 9 8 0 0   Employee growth %   0.0% -10.0% 11.1% 0.0% -10.0% -11.1% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   29,542 28,092 34,936 42,669 54,263 56,030 24,015 24,015   Balance sheet change%   22.1% -4.9% 24.4% 22.1% 27.2% 3.3% -57.1% 0.0%   Added value   5,718.0 5,347.0 8,945.0 9,345.0 8,523.0 3,690.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -1,257 -519 -366 8,569 -4,552 -4,300 -18,006 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   41.4% 38.7% 49.9% 45.9% 40.9% 5.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   17.8% 15.2% 24.5% 19.4% 14.1% 2.6% 0.0% 0.0%   ROI %   22.4% 18.9% 32.0% 26.1% 17.0% 2.9% 0.0% 0.0%   ROE %   53.5% 35.7% 51.7% 34.4% 21.8% 0.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   23.3% 27.0% 36.8% 43.5% 45.1% 43.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   292.5% 261.6% 124.1% 134.5% 238.4% 594.5% 0.0% 0.0%   Gearing %   246.6% 186.3% 90.3% 69.1% 92.4% 89.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.5% 6.7% 7.2% 5.8% 4.9% 6.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.1 1.0 1.1 0.9 1.2 1.4 0.0 0.0   Current Ratio   1.4 1.6 1.8 1.6 1.9 1.8 0.0 0.0   Cash and cash equivalent   233.0 146.0 524.0 20.0 37.0 103.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   6,479.0 7,088.0 11,204.0 8,076.0 16,798.0 17,367.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   572 594 895 935 947 461 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   572 594 895 935 1,053 461 0 0   EBIT / employee   453 447 747 722 711 59 0 0   Net earnings / employee   290 287 529 534 518 3 0 0